Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 19/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | NSD2 | O96028 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8054280 | 0.89 | EDNRA (1.00) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8396364 | 0.84 | EDNRA (0.72) | EDNRATSHR | |
| SCHEMBL8058105 | 0.81 | EDNRA (1.00) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8055569 | 0.80 | EDNRA (0.76) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8055525 | 0.80 | EDNRA (1.00) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8060425 | 0.80 | EDNRA (1.00) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8042538 | 0.78 | EDNRA (0.72) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8060550 | 0.77 | EDNRA (0.71) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8891516 | 0.75 | EDNRA (1.00) | EDNRAKDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL8055562 | 0.75 | EDNRA (0.67) | EDNRAKDM4ENSD2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6083951-A | FOR THE TREATMENT OF DISEASES OR MEDICAL CONDITIONS SUCH AS HYPERTENSION, PULMONARY HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE | ZENECA LIMITED (GB) | 2000-07-04 | — | — | US | disclosed |
| US-5861401-A | TREATMENT OF CONGESTIVE HEART FAILURE | ZENECA LIMITED (GB) | 1999-01-19 | — | — | US | disclosed |